JP2023516705A5 - - Google Patents

Info

Publication number
JP2023516705A5
JP2023516705A5 JP2022552853A JP2022552853A JP2023516705A5 JP 2023516705 A5 JP2023516705 A5 JP 2023516705A5 JP 2022552853 A JP2022552853 A JP 2022552853A JP 2022552853 A JP2022552853 A JP 2022552853A JP 2023516705 A5 JP2023516705 A5 JP 2023516705A5
Authority
JP
Japan
Prior art keywords
sequence
cdr
antigen
fragment
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022552853A
Other languages
English (en)
Japanese (ja)
Other versions
JP7827630B2 (ja
JP2023516705A (ja
Filing date
Publication date
Priority claimed from EP20160712.4A external-priority patent/EP3875482A1/en
Application filed filed Critical
Publication of JP2023516705A publication Critical patent/JP2023516705A/ja
Publication of JP2023516705A5 publication Critical patent/JP2023516705A5/ja
Application granted granted Critical
Publication of JP7827630B2 publication Critical patent/JP7827630B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022552853A 2020-03-03 2021-03-01 前立腺がんを診断するための新規な方法と化合物 Active JP7827630B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20160712.4 2020-03-03
EP20160712.4A EP3875482A1 (en) 2020-03-03 2020-03-03 New method and compound for prostate cancer diagnosis
PCT/EP2021/055061 WO2021175788A1 (en) 2020-03-03 2021-03-01 New method and compound for prostate cancer diagnosis

Publications (3)

Publication Number Publication Date
JP2023516705A JP2023516705A (ja) 2023-04-20
JP2023516705A5 true JP2023516705A5 (cg-RX-API-DMAC10.html) 2024-02-26
JP7827630B2 JP7827630B2 (ja) 2026-03-10

Family

ID=69770502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022552853A Active JP7827630B2 (ja) 2020-03-03 2021-03-01 前立腺がんを診断するための新規な方法と化合物

Country Status (7)

Country Link
US (1) US20230093265A1 (cg-RX-API-DMAC10.html)
EP (2) EP3875482A1 (cg-RX-API-DMAC10.html)
JP (1) JP7827630B2 (cg-RX-API-DMAC10.html)
CN (1) CN115210256A (cg-RX-API-DMAC10.html)
AU (1) AU2021232524A1 (cg-RX-API-DMAC10.html)
CA (1) CA3168158A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021175788A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI131968B1 (en) * 2023-10-16 2026-03-17 Teknologian Tutkimuskeskus Vtt Oy ANTIBODY BINDINGS AS CANCER BIOMARKERS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999012553A1 (en) * 1997-09-08 1999-03-18 Idec Pharmaceuticals Corporation Methods for producing human antibodies in scid mice using dendritic cells
SE535084C2 (sv) * 2010-04-16 2012-04-10 Prostasom Handelsbolag Förfarande för cancerdiagnos
US9029086B2 (en) * 2012-01-26 2015-05-12 Masood Kamali Moghaddam Detection of single and multimodal analytes

Similar Documents

Publication Publication Date Title
JP2022521551A5 (cg-RX-API-DMAC10.html)
JP2021517152A5 (cg-RX-API-DMAC10.html)
US9841430B2 (en) Fractional C-reactive protein (fracCRP) antibodies and assays
JP2017524362A5 (cg-RX-API-DMAC10.html)
EP2785740A1 (en) Anti-glucagon antibodies and uses thereof
JP7557023B2 (ja) 多発性骨髄腫におけるｍタンパク質反応の臨床評価
JP2018525320A5 (cg-RX-API-DMAC10.html)
AU2017204683B2 (en) Compositions and methods for assessing the risk of cancer occurrence
JP2005535562A5 (cg-RX-API-DMAC10.html)
WO2018178352A1 (en) Compositions and methods for detecting prostate cancer
JP2025505650A5 (cg-RX-API-DMAC10.html)
JP2022521973A5 (cg-RX-API-DMAC10.html)
JP2024509501A5 (cg-RX-API-DMAC10.html)
JP2019513004A5 (cg-RX-API-DMAC10.html)
KR102078879B1 (ko) 돼지파보바이러스에 특이적인 단일클론항체 및 이의 용도
JP2024544885A5 (cg-RX-API-DMAC10.html)
JP2018524270A5 (cg-RX-API-DMAC10.html)
JP2023508706A (ja) 腫瘍免疫抑制因子に不応性の操作されたモノクローナル抗体の組成物及び使用
JP7827630B2 (ja) 前立腺がんを診断するための新規な方法と化合物
WO2022238481A1 (en) Antibodies
JP2023547167A (ja) コロナウイルススパイクタンパク質に特異的な抗体及びその用途
CN119264254B (zh) 抗降钙素原抗体及包括该抗体的检测试剂盒
KR20160093503A (ko) 항 crs 모노클로날 항체 및 이의 용도
FI131968B1 (en) ANTIBODY BINDINGS AS CANCER BIOMARKERS
KR20180041466A (ko) 코어-푸코실화된 알파-페토프로테인에 특이적으로 결합하는 항체 및 그의 용도